Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma
Author Information
Author(s): Gram Stine Bjørn MD PhD, Brusgaard Klaus MSc PhD, Lei Ulrikke MD, Sommerlund Mette MD PhD, Vinding Gabrielle Randskov MD PhD, Sleire Sondre Olai Kjellevold MS, Christensen Alex Hørby MD PhD, Fast Sanne Pedersen MD, Bach Rasmus MD, Bygum Anette MD DMSc, Ousager Lilian Bomme MD PhD
Primary Institution: Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
Hypothesis
What is the clinical and genetic spectrum in a large cohort of Danish patients with palmoplantar keratoderma?
Conclusion
This study provides novel insights into the clinical and genetic spectrum of patients with palmoplantar keratoderma.
Supporting Evidence
- A genetic diagnosis was found in 63 of 76 families (83%).
- 27 disease-causing variants were identified across 13 genes.
- AAGAB variants correlated with punctate palmoplantar keratoderma.
- Patients with DSP variants were found to have an associated risk of cardiomyopathy.
- Most patients reported pain or soreness associated with PPK.
Takeaway
This study looked at a group of people with a skin condition called palmoplantar keratoderma to understand their symptoms and genes better. They found that many had a specific gene change that helps explain their condition.
Methodology
This cohort study prospectively recruited patients and affected family members with palmoplantar keratoderma and performed genetic testing.
Potential Biases
Patients with more severe disease may have been more prone to seek medical advice.
Limitations
The cohort may not fully represent all patients with PPK in Denmark due to non-uniform recruitment and potential bias in participant selection.
Participant Demographics
142 participants from 76 families, 63% female, median age 52 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website